Clinical Trial Update: Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update addressing thrombocytopenia and bleeding in patients with Wiskott-Aldrich Syndrome; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding
• Thrombocytopenia
• Wiskott-aldrich Syndrome

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Wiskott-Aldrich Syndrome, Thrombocytopenia | Phase 2 | Status: TERMINATED | Results posted: 2019-03-18